Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|March 31, 2025
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 DiabetesDarren K McGuire, Nikolaus Marx, Sharon L Mulvagh, et al.
American Heart Journal|December 24, 2024
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinicsAdam J Nelson, Lisa A Kaltenbach, Darren K McGuire, et al.
American Journal of Preventive Cardiology|August 14, 2025
Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trialAdam J Nelson, Lisa A Kaltenbach, Hussein R Al-Khalidi, et al.
Circulation|July 6, 2021
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology CommunityAdam J Nelson, Neha J Pagidipati, Vanita R Aroda, et al.
Pain Practice : the Official Journal of World Institute of Pain|June 20, 2025
Systematic Review on Minimally Invasive Posterior Sacroiliac Joint FusionBenjamin Gill, Hamzah Adel Ramawad, Patrick Buchanan, et al.
JAMA Network Open|February 17, 2022
Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular DiseaseAdam J Nelson, Emily C O'Brien, Lisa A Kaltenbach, et al.
Circulation|June 27, 2024
Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes TrialManasi Tannu, Lisa Kaltenbach, Neha J Pagidipati, et al.
Cardiovascular Diabetology|August 1, 2021
Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL dataKamlesh Khunti, Mikhail Kosiborod, Dae Jung Kim, et al.
Journal of Pain Research|September 16, 2021
Latest Evidence-Based Application for Radiofrequency Neurotomy (LEARN): Best Practice Guidelines from the American Society of Pain and Neuroscience (ASPN)David W Lee, Scott Pritzlaff, Michael J Jung, et al.
BMC Cancer|December 29, 2019
In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cellsJustin J Montoya, Megan A Turnidge, Daniel H Wai, et al.
Pageof 15